Acorda In The News

July 2018 – Drug Delivery Business

CEO Ron Cohen, M.D., discusses “Failure, perseverance and the profound risks of drug development”.

November 2017 – MM&M/PR Week

CEO Ron Cohen, M.D., is named one of the top 50 health influencers of 2017.

June 2017 - American Healthcare Leader

President, International and General Counsel Jane Wasman profiled in American Healthcare Leader.

April 2017 - International In-House Counsel Journal

President, International and General Counsel Jane Wasman discusses the legal aspects of Acorda’s acquisition of Finnish-based Biotie Therapies.

March 2017 - Journal News

President, International and General Counsel Jane Wasman penned an op ed for the Journal News on why New York is smart to support the life sciences.

February 2017 - Medical Marketing & Media

CEO Ron Cohen, M.D., featured in, “On Drug Pricing, Acorda CEO is Optimistic”

December 2016 - CNBC Halftime Report

November 2016 - 914INC.

EVP, Corporate Communications, Tierney Saccavino was profiled in a feature on Westchester county’s top female executives

October 2016 - United Press International

UPI covers the publication of our CVT-301 data in the journal Science Translational Medicine.

October 2016 - White Plains Daily Voice

A profile on our Scientific Excellence Award

September 2016 - Forbes

Ron Cohen, M.D., and five other biotech CEOs co-authored an editorial on the importance of protecting innovation in light of the controversy over Mylan’s price hikes on the EpiPen

May 2016 - PM360

Rich Muser recognized with PM360’s ELITE Award

May 2016 - 914INC.

EVP Tierney Saccavino quoted on our Scientific Excellence Award

April 2016 – Washington Post

CEO Ron Cohen quoted in an Article on the patient’s voice in drug development
View article

March 2016 - Xconomy

Q&A with BIO Chair and Acorda CEO Ron Cohen

March 2016 - WLFI

Eighteen Purdue innovators who have shaped the modern world

January 2016 - CNBC Closing Bell

January 2016 - Human Proof of Concept

Ron Cohen: Founder & Confounder
Listen to Podcast: Part 1   Part 2

December 2015 – Life Science Leader

Ron Cohen, M.D., “What Is Required For Continued Healthcare Value Creation?” p. 17

November 2015 - Power of Ideas

Ron Cohen, M.D., “Partnering with Patients on Drug Development”

August 2015 - Practical Neurology

Data on CVT-301 Presented at Medical Meeting

May 2015 - PM360

Pasqual Zottola, Jonathan Kuhn and Mike Russo recognized with PM360’s ELITE Award

May 2015 - Westchester Magazine

Wunderkinds Class of 2015

March 2015 - Westchester County Business Journal

Raw Beauty Project NYC Exhibit

February 2015 – 914Inc.

All-Westchester Companies

February 2015 - FierceBiotech

Andrew Blight Discusses Phase 1 rHIgM22 Results

January 2015 – The Daily Voice

Blind Brook’s Brian Becker Receives Acorda Scientific Excellence Award

January 2015 – Mad Money with Jim Cramer

September 2014 - The RPM Report

Ron Cohen, M.D. Op-Ed: To Curb Medical Costs, Let Market Forces Do their Job

November 2014 - Baseline Magazine

Acorda: Taking a Therapeutic Approach to Collaboration

October 2014 - Investor's Business Daily

Civitas Acquisition: Q&A with Ron Cohen, M.D.

October 2014 - Westchester Magazine

Westchester’s Biotech Industry

October 2014 – Mad Money with Jim Cramer

September 2014 - Westchester County Business Journal

Acorda to Acquire Civitas Therapeutics

September 2014 - IR Magazine

Latest NIRI interns get to grips with IR

September 2014 – HR Executive

Lessons from Recruiting in Pharma

July 2014 – Forbes

Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?

March 2014 – Xconomy

10 Takeaways From New York’s Life Science Disruptors

January 2014 – Bloomberg News

M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals

January 2014 – Forefront Magazine

Lab Tests for Your Legal Department

December 2013 – PM360

Recruiting and Retaining the Best Talent

November 2013 - Latin Business Today

The High Tech Brain Gain And STEM

November 2013 - 914Inc.

Acorda’s Jane Wasman Featured in 914Inc.’s Annual “Women in Business” Issue

October 2013 - The Rivertowns Enterprise

Acorda and WFAS Team Up on High School Science Award

October 2013 - The Deal Pipeline

Intended consequences

July 2013 – Pharmaceutical Executive

Pharma Exec’s 2013 Emerging Pharma Leaders

July 2013 – PM360

Optimizing the Client-Agency Relationship

July 2013 – Genetic Engineering & Biotechnology News

HTRF Applications in New Drug Discovery

June 2013 – Mashable

One Man’s Mission to Map More Accessible Cities

June 2013 – Brain Blogger

Promoting Remyelination in Multiple Sclerosis – an Interview on rHIgM22

June 2013 – The RPM Report

Medicare’s Independent Payment Advisory Board: First, Do No Harm

May 2013 – Genetic Engineering & Biotechnology News

Pharma Builds Bridges with Advocacy Groups

May 2013 – Corporate Counsel

Best Legal Departments 2013 - Acorda Therapeutics: Scrappy But Savvy

January 2013 – Forbes

How The U.S. Can Attract Biotech Firms by Imitating China

September 2012 – Pharmaceutical Executive

Upgrading the Tax Code to Bolster Biotech

March 2012 – Pharmaceutical Executive

FDA’s Necessary Dose of Reality

July 2011 – Xconomy

Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline

May 2011 – The Scientist

Best Places to Work in Industry, 2011

March 2011 – Life Science Leader

When Your Science Leads to an Unexpected Business Opportunity

February 2011 – 914Inc.

Westchester’s MedMen: The Classmates-Turned-Competitors Behind the County’s Biotech Boom